Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Capital Expenditures (2016 - 2025)

CV Sciences' Capital Expenditures history spans 11 years, with the latest figure at $11000.0 for Q3 2025.

  • For Q3 2025, Capital Expenditures changed N/A year-over-year to $11000.0; the TTM value through Sep 2025 reached $118000.0, changed N/A, while the annual FY2024 figure was $18000.0, N/A changed from the prior year.
  • Capital Expenditures for Q3 2025 was $11000.0 at CV Sciences, down from $49000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $49000.0 in Q2 2025 and bottomed at $7000.0 in Q1 2021.
  • The 3-year median for Capital Expenditures is $23000.0 (2021), against an average of $25500.0.
  • The largest YoY upside for Capital Expenditures was 88.84% in 2021 against a maximum downside of 90.79% in 2021.
  • A 3-year view of Capital Expenditures shows it stood at $28000.0 in 2021, then plummeted by 35.71% to $18000.0 in 2024, then tumbled by 38.89% to $11000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Capital Expenditures are $11000.0 (Q3 2025), $49000.0 (Q2 2025), and $40000.0 (Q1 2025).